Moleculin Biotech (MBRX) Tops Q2 EPS by 7c

Moleculin Biotech (NASDAQ: MBRX) reported Q2 EPS of ($0.20), $0.07 better than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Moleculin Biotech (MBRX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy
• Danone SA (BN:FP) (DANOY) PT Raised to EUR63 at Deutsche Bank